Drugs / Allogenic MSCs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05086939 | May 2021 → May 2025 overdue | osteoarthritis, knee | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05086939 ↗ |
| Modality | Cell therapy | “adult allogeneic expanded bone marrow mesenchymal stem cells” NCT05086939 ↗ |
| Route | Other | “administered intra-articularly” NCT05086939 ↗ |